Andréanne Auger

For the past 15 years, Andréanne Auger has been helping her clients manage their IP assets. Her client base includes many medium-sized and established Canadian, French and US companies seeking to protect and market their inventions in North America, in Europe and internationally.

Ms Auger principally advises clients in the biotechnology and medical devices areas that are active in the fields of molecular and cellular biology, genetics, chemistry, biology and biochemistry. She provides them with a solid, coherent IP programme that brings value to their business objectives. She has vast experience in assisting clients with growing patent assets from their creation to monetisation.

Her expertise lies particularly in helping companies coordinate and manage the protection of intellectual property emerging from R&D activities occurring in multiple jurisdictions; and in creating IP rights around technologies targeted for the European and North American markets.

She is routinely involved in the preparation of validity and patentability opinions and analyses of patent portfolios and potential infringement in the context of financings or acquisitions.

Ms Auger holds a PhD in cellular and molecular biology. She is involved in many national and international projects on this subject. She sits on BCF’s board of directors and succession plan committee.